Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Escherichia coli ST131

PROVIDER: PRJNA683640 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR13220449_1.fastq.gz	Fastqsanger.gz
	SRR13220449_2.fastq.gz	Fastqsanger.gz
	SRR13220450_1.fastq.gz	Fastqsanger.gz
	SRR13220450_2.fastq.gz	Fastqsanger.gz
	SRR13220451_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

Comprehensive Assessment of Initial Adaptation of ESBL Positive ST131 E. coli to Carbapenem Exposure

Project description:Background: It remains unclear how high-risk Escherichia coli lineages, like sequence type (ST) 131, initially adapt to carbapenem exposure in its progression to becoming carbapenem resistant. Methods: Carbapenem mutation frequency was measured in multiple subclades of extended-spectrum β-lactamase (ESBL) positive ST131 clinical isolates using a fluctuation assay followed by whole genome sequencing (WGS) characterization. Genomic, transcriptomic, and porin analyses of ST131 C2/H30Rx isolate, MB1860, under prolonged, increasing carbapenem exposure was performed using two distinct experimental evolutionary platforms to measure fast vs. slow adaptation. Results: All thirteen ESBL positive ST131 strains selected from a diverse (n=184) ST131 bacteremia cohort had detectable ertapenem (ETP) mutational frequencies with a statistically positive correlation between initial ESBL gene copy number and mutation frequency (r = 0.87, P<1e-5). WGS analysis of mutants showed initial response to ETP exposure resulted in significant increases in ESBL gene copy numbers or mutations in outer membrane porin (Omp) encoding genes in the absence of ESBL gene amplification with subclade specific adaptations. In both experimental evolutionary platforms, MB1860 responded to initial ETP exposure by increasing blaCTX-M-15 copy numbers via modular, insertion sequence 26 (IS26) mediated pseudocompound transposons (PCTns). Transposase activity driven by PCTn upregulation was a conserved expression signal in both experimental evolutionary platforms. Stable mutations in Omp encoding genes were detected only after prolonged increasing carbapenem exposure consistent with clinical observations. Conclusions: ESBL gene amplification is a conserved response to initial carbapenem exposure, especially within the high-risk ST131 C2 subclade. Targeting such amplification could assist with mitigating carbapenem resistance development.

2024-08-04 | GSE273456 | GEO

Escherichia coli O25b:H4-ST131

Project description:Escherichia coli ST131 plasmids

| PRJNA494636 | ENA

blaCTX-m

Project description:Escherichia coli ST131 in Germany

| PRJEB21171 | ENA

Escherichia coli

Project description:Comparative genomics of Escherichia coli ST131

| PRJNA335983 | ENA

Project description:ESBL-producing Escherichia coli of ST131

| PRJNA790005 | ENA

Four main virotypes Escherichia coli ST131

Project description:Four main virotypes Escherichia coli ST131

| PRJEB6262 | ENA

Study for investigating the effects of a probiotic on diarrhea caused by chemotherapy in patients with gastric, colon and rectum cancer

Project description:Primary objectives: The study investigates whether a Escherichia coli Nissle-suspenison has a (preventive) antidiarrheal effect in patients with tumors who are treated with chemotherapeutic schemes which are associated with increased occurances of diarrhea. Diarrhea caused by treatment are thought to be reduced in intensity and/or frequency by the treatment with Escherichia coli Nissle-Suspension. Primary endpoints: Common toxicity criteria (CTC) for diarrhea

| 2534265 | ecrin-mdr-crc

Escherichia coli

Project description:Whole genome sequencing of Escherichia coli ST131

| PRJDB3868 | ENA

Escherichia coli O25b:H4-ST131

Project description:Escherichia coli O25b:H4-ST131 Genome sequencing

| PRJNA211153 | ENA

Project description:Sequencing of ST131-H22 Escherichia coli strains

| PRJNA508590 | ENA